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Abstract Transthyretins isolated from different species bind hy- 
drophobic compounds and are often obtained in a yellow form. 
Such a transthyretin from chicken serum was purified by chrom- 
atography using Sepharose-coupled human retinol-binding pro- 
tein. The yellow chromophore was extracted with methanol and 
purified by reverse phase HPLC followed by normal-phase 
chromatography on a nitrile column. Ultraviolet-visible absorb- 
ance and mass spectrometry identified the yellow compound as 
iutein, i.e. xanthophyll, (all-trans)-~,e-carotene-3,3"-diol, esti- 
mated to constitute 10-30% of associated eolourless compounds. 
These components are different from the yellow component iso- 
lated from human transthyretin and establish that carotenoid- 
derived pigments can be associated with transthyretins. 
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Yellow component; Mass spectrometry 
1. Introduction 
Human transthyretin (TTR) is known in three-dimensional 
structure at 1.8 A resolution [1], occurs in many different forms 
[2], and is associated with other compounds, including yellow 
component(s) found in TTR from mammalian and avian forms 
of the protein [3]. Transthyretin has two well-established func- 
tions; one is the transport of thyroxine [4], the other the trans- 
port of retinol via the TTR-associated retinol binding protein 
(RBP) [5], but other functions have also been considered. The 
protein is structurally well conserved throughout evolution [6], 
particularly in its thyroxine-binding channel, but TTR is not 
essential for life as it is absent in amphibian and lower verte- 
brate branches [7], and as TTR-null-mutant mice survive, are 
euthyroid, and reproduce, although with reduced levels of triio- 
dothyronine and thyroxine, as well as extremely low levels of 
retinol and RBP [8]. 
TTR is synthesized mainly in the liver, but also in the choroid 
plexus. While, the synthesis in the choroid plexus is found in 
species down to reptiles, that in liver is found only in mammals, 
one group of marsupials, and birds [6,7,9]. TTR is also pro- 
duced in the c~ cells of the human Langerhan's i lets, but in the 
ft cells or in both theft and ~ cells in other species [10]. Further- 
more, specific cells in the gastrointestinal tract produce TTR, 
in particular in the fetus [11], as do the pigment epithelial cells 
of the retina [12] and cells in the pineal gland [13]. Human TTR 
is involved in pathological conditions characterized by amyloid 
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deposits associated with both senile [14] and familial forms [15] 
of systemic amyloidosis. A number of TTR variants with single 
amino acid substitutions how increased ability to form the 
amyloid deposits. Yellow component(s) are present also in am- 
yloid transthyretin [16]. 
This paper reports on the isolation of the yellow compound 
from chicken TTR and identifies it as the hydroxylated caro- 
tene derivative lutein. While other compounds may constitute 
yellow TTR ligands in other species, this work recognizes a
novel multiplicity in TTR ligands by addition of carotenoid- 
derived ligands. 
2. Materials and methods 
2.1. Protein purification 
Chicken blood was collected at an abattoir and serum was separated 
from the retracted blood cells without centrifugation. Outdated plasma 
was used as source of human TTR. For isolation of chicken RBP and 
TTR, respectively, Sepharose coupled with human TTR or human RBP 
was prepared [17]. Before isolation of TTR, RBP was eliminated from 
the serum by affinity chromatography on human TTR-Sepharose. A 
total of 40 litres of chicken serum was processed on two different 
occasions. Agarose electrophoresis [18], isoelectric focusing [2], and 
polyacrylamide g l electrophoresis under native conditions and in the 
presence of SDS [19] were performed as described. 
2.2. Purification of yellow component 
Purified TTR and RBP were desalted on Sephadex G-25 Fine and 
lyophilized. Methanol was added and the mixture was shaken for 10 
min. The proteins were removed by centrifugation a d the supernatants 
evaporated todryness. The yellow extract from chicken TTR, the reti- 
nol extract of chicken RBP, and the extract from human TTR were 
stored in methanol at -70°C. The methanol extracts were studied by 
capillary electrophoresis in a Beckman PLACE 2000 instrument using 
a mixture of 0.05 M phosphate buffer, pH 2.5, and methanol (1:4) at 
20 kV for 40 min with monitoring at 200 nm. For HPLC purification, 
the yellow methanol extract from chicken TTR was applied to a semi- 
preparative reverse phase C18 column (Nucleosil 5, 100 A, 250 × 10 
mm; Phenomenex, Scandinavian Genetec, Kungsbacka, Sweden) 
eluted with a methanol gradient in water at a flow rate of 3 ml/min. The 
eluent was monitored at 260 and 444 nm. The yellow material eluted 
as a single chromatographic peak and was purified further by normal- 
phase HPLC on a Nucleosil 5CN nitrile column (Scandinavian Gene- 
tec) in the solvent system hexaneldichloromethanelmethanollN, N- 
diisopropylethylamine (74.65 :25.00 :0.25 :0.10) [20]. The yellow mate- 
rial eluted as a single chromatographic peak and was collected for 
structural studies. Xanthophyll ( utein) from Sigma was purified in the 
same manner, fl-Carotene was also obtained from Sigma. 
2.3. Spectrometry 
The absorption spectra of the compounds i olated from chicken and 
human TTR, respectively, were recorded from 200 to 600 nm in a 
Hitachi U3200 spectrophotometer andcompared with that of the refer- 
ence lutein. The molecular weight of the isolated yellow compound 
from chicken TTR was determined by mass spectrometry using a VG 
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Auto Spec-Q instrument, equipped with a fast-atom bombardment 
(FAB) source and a cesium ion gun operated at an anode potential of 
25 kV. The samples were dissolved in 70% methanol and 5 10 ¢tl were 
applied to the FAB target coated with a matrix of glycerol/nitrobenzyl 
alcohol (1 : 1 v/v). Positive ion spectra were recorded at an accelerating 
voltage of 8 kV and a resolution of 1000 (5% valley). 
3. Results 
The positive ion FAB mass spectra of the reference lutein and 
the compound extracted from TTR showed an intense ion at 
m/z 568 and a fragment ion at m/z 551 (Fig. 3). These corre- 
spond to the radical cation of lutein and to loss of water from 
a protonated molecular ion, respectively. These results identify 
the yellow component associated with chicken TTR as the most 
common isomer of lutein, (all-trans)-fl,e-carotene-3,Y-diol 
(Fig. 4). 
3.1. Chicken TTR 
Affinity chromatography of TTR from chicken serum re- 
sulted in a product of high purity (> 98%) as judged by electro- 
phoresis (Fig. 1A). Chicken TTR presented the same type of 
microheterogeneity pattern as human TTR upon non-denatu- 
rating (Fig. 1 B) and denaturating isoelectric focusing. The puri- 
fied chicken TTR was visibly yellow at a concentration f 10 
mg/ml. The protein remaining after methanol extraction was 
uncoloured. Upon reverse-phase HPLC, the methanol extract 
showed only one peak with absorbance in the visible range. 
However, several other peaks with absorbance below 350 nm 
were separable (Fig. 2A). The total amount of extractable ma- 
terial varied between TTR preparations, from 2% to 6% of the 
mass of the lyophilized material, with the yellow compound 
constituting 10-30% (w/w) of the extracts. A peak correspond- 
ing to thyroxine was identified (Fig. 2A), and retinol was pres- 
ent (Fig. 2A) because of a minor contamination f the TTR 
preparation with RBP (Fig. lA). Elimination of RBP from the 
TTR preparation also eliminated retinol from the methanol 
extract. The normal phase HPLC system was capable of sepa- 
rating isoforms ofhydroxylated carotenoids, but identified only 
one peak at both 260 and 444 nm, with an elution time identical 
to that of the lutein reference. The ultraviolet-visible spectra of 
the yellow compound from chicken TTR and the lutein stand- 
ard were identical (Fig. 2B). 
3.2. Human TTR 
Methanol extracts of human TTR were yellow, but to a lesser 
extent than those chicken-derived. However, extraction of 
human TTR at acidic pH (~ 2) and elevated temperatures (100 ° C 
for 5 10 min) can result in the recovery of a highly yellow 
substance with absorbance maxima at 268, 282 and 430 nm 
(Fig. 2B), interpreted toconstitute a pterin derivative [21]. Mass 
spectrometric studies of that material have so far been unsuc- 
cessful. However, capillary electrophoresis has resolved ex- 
tracts from both chicken and human TTR into two groups of 
major peaks at identical positions but in different ratios. 
4. Discussion 
4.1. Yellow component in chicken TTR 
Most carotenoids have a typical spectrum with three strong 
absorbance maxima in the region 400-550 nm and weak max- 
ima in the 260-280 and 320-350 nm regions [22]. The spectrum 
of purified chicken TTR shows this pattern and is identical to 
that of lutein. The mass spectrum also indicates that the yellow 
carotenoid associated with chicken TTR is lutein. The lutein 
content of the total methanol extract is approximately 1~30% 
by weight. The other components, identified by their 260 nm 
absorbance, lute before lutein. Mass spectra of these compo- 
nents indicate molecular weights between 280 and 498 Da, 
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Fig. 1. Agarose lectrophoresis (A) in 0.075 M barbital buffer, pH 8.6, of purified chicken TTR (cTTR, left lane), and purified chicken RBP (cRBP; 
right lane) after one step of purification on Sepharose-human RBP and Sepharose-human TTR, respectively. Isoelectric focusing (B) of isolated 
chicken TTR (left lane) compared with that of human TTR (hTTR; right lane). The purified TTR in A is slightly contaminated with chicken RBP 
in TTR complex as indicated. Protein staining by amido black in A and Coomassie brilliant blue in B. 
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Fig. 2. Chromatogram at 260 nm (A) of chicken TTR methanol extract 
subjected to reverse-phase HPLC in methanol/water with a gradient 
from 20% to 100% methanol in 15 min, 100% methanol for 10 rain and 
back to 20% methanol in 5 min. Peaks 1-6 represent major components, 
that in peak 6 is strongly ellow (Y) with three absorbance maxima s 
indicated in B, middle panel. The shoulder corresponding to thyroxine 
(T4) and the peak corresponding to retinol (R) are also indicated. In 
B, the top two panels how the similarity between the spectra of the 
chicken TTR yellow component and the lutein reference, while the 
bottom panel shows the difference toward the spectrum of the human 
TTR yellow component. 
while preliminary NMR studies indicate structural similarities 
to lutein, suggesting that many of the components extracted 
from chicken TTR could be oxidized carotenoid products [22]. 
The extent oflutein saturation of chicken TTR was estimated 
to be about 50%, assuming a molar ratio of one lutein per 
protein tetramer as the maximum binding. This extent of satu- 
ration is much higher than that with thyroxine in vivo (which 
is about 1% for human TTR and about 0.14).2% for chicken 
TTR) but of similar magnitude as that with the retinol RBP 
complex (which with TTR forms a 1 : 1 complex in human [23] 
and a 2: 1 complex in chicken [24]). The differences inthyroxine 
and retinol-RBP binding between human and chicken TTR 
may relate to the association of lutein and other components 
to the proteins. Notably, the association of lutein is a specific 
finding for TTR, as no lutein could be identified in similar 
extracts of chicken RBP. Also, the binding seems to be specific 
for lutein, as none of the common hydrophobic fl- and c~- 
carotenes were ibund to be associated with TTR. In human, 
both hydrophobic and hydroxylated carotenoids are trans- 
ported mainly by lipoproteins [25], which are less abundant in
chicken plasma, further illustrating the different patterns. 
4.2. Yellow component in human TTR 
Mammalian TTRs also contain associated compounds, in- 
cluding a yellow component. I s absorption spectrum, stability, 
and chromatographic behaviour are different from those of 
lutein. The major compound appears to be a pterin-derivative 
[21], but the presence of additional, carotenoid-derived compo- 
nents hould not be excluded. TTR synthesized in liver contrib- 
utes to the transport of thyroxine to the peripheral tissues, while 
TTR synthesis in the choroid plexus is considered exclusively 
to transport thyroxine into the brain [26]. In human, thyroxine 
is transported bound to TTR (40%), thyroxine-binding globu- 
lin, TBG (50%) and albumin (10%) [27]. Chicken plasma con- 
tains no TBG, and about 80% of its thyroxine is transported 
by albumin, with less than 20% (about 4 nmol/1) by TTR, 
although the concentrations of TTR are similar in chicken and 
human plasma (unpublished observation). Hence, thyroxine 
binding to TTR is significantly lower in chicken than human 
plasma. Independent of exact function, the ligands now re- 
ported may contribute an explanation to the multiplicity of 
TTR forms and functions, as well as to the species-specific 
regulatory pattern of TTR in thyroxine binding. Interestingly, 
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Fig. 3. Positive ion FAB mass pectra of reference lutein (A) and the 
yellow ligand extracted from chicken TTR (B), both purified by reverse- 
phase HPLC. The ions at mJz 568 and m/z 551 correspond to lutein 
dervatives (radical cation, and loss of water from a protonated molec- 
ular ion, respectively). Peaks marked * originate from the matrix. 
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Fig. 4. Structure of the lutein isoform associated with chicken TTR. 
the major coloured compounds of the retina are lutein and its 
isoform zeaxanthin [28]. 
Yellow and uncoloured components are present also in TTR 
associated with human familial amyloidotic ardiomyopathy 
[16], characterized by deposition of mutationally altered TTR 
and its fragments as amyloid fibrils. Hence, the association of 
ligands, including lutein and other carotenoids, is of pathophys- 
iological interest. 
4.3. Conclusion 
The specific binding of lutein to chicken TTR recognizes 
carotenoids as TTR ligands. Together with previous conclu- 
sions on pterin binding to human TTR this emphasizes multiple 
transport functions of transthyretins. In particular, the findings 
offer an explanation for the disputed role of TTR in the retina 
and for the presence of ligands in disease-related amyloid de- 
posits of TTR. 
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